InvestorsHub Logo
Followers 253
Posts 17994
Boards Moderated 0
Alias Born 01/19/2006

Re: haysaw post# 92062

Wednesday, 09/14/2016 12:30:14 PM

Wednesday, September 14, 2016 12:30:14 PM

Post# of 426486
ACASTI apparently intends to compete with Lovaza and its generic with that product that is derived from krill oil. Note there is no mention of % EPA content of the product in that PR.

As such, I personally am not concerned, particularly in light of recent scrip information reported by Sam for Vascepa, Lovaza and gL...I wonder how much that Acasti product resembles its Omega-3 Red that is now sold OTC?

I have no thoughts on time frame for its Phase 3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News